Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRISMA 7 (for Frailty Assessment) and SARC-F (for Evaluation of Sarcopenia Risk) in Predicting Emergency Department Readmission and Mortality

NCT06525038 is registered in ClinicalTrials.gov with Firat University as lead sponsor.

NCT NCT06525038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06525038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRISMA 7 (for Frailty Assessment) and SARC-F (for Evaluation of Sarcopenia Risk) in Predicting Emergency Department Readmission and Mortality
Lead sponsor
Firat University
Phase
Observational
Overall status
Completed
Start date
January 1, 2023
Completion date
September 30, 2023
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frailty, morality, sarcopenia